WIA
HAE icon

World Investment Advisors’s Haemonetics HAE Stock Holding History

World Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,075
Closed -$246K – 1614
2025
Q4 		$246K Buy
+3,075
New +$207K ﹤0.01% 1281

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

World Investment Advisors's HAE Position: Q1 2026 in Review

World Investment Advisors sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 3,075 shares — an estimated $246K sold.

World Investment Advisors first reported a position in HAE in Q4 2025 and held it in 1 quarter. The position peaked at $246K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • World Investment Advisors reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • World Investment Advisors sold 3,075 Haemonetics shares in Q1 2026, an estimated $246K.
  • World Investment Advisors first reported a position in Haemonetics in Q4 2025 and held it in 1 quarter.
  • World Investment Advisors's Haemonetics position peaked at $246K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on World Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.